Elekta (OTCMKTS:EKTAY) Posts Quarterly Earnings Results

by · The Cerbat Gem

Elekta (OTCMKTS:EKTAY – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.06 EPS for the quarter, Zacks reports. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%.

Elekta Stock Down 13.9%

EKTAY stock opened at $5.71 on Friday. The firm has a market cap of $2.10 billion, a PE ratio of -570.43 and a beta of 1.01. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95. The firm’s 50 day moving average price is $6.01 and its 200-day moving average price is $5.99. Elekta has a one year low of $4.35 and a one year high of $6.93.

About Elekta

(Get Free Report)

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.

Recommended Stories